Vimab Group AB (publ) 

€0.22
3
-€0.01-6.33% Thursday 07:08

統計

當日最高
0.24
當日最低
0.24
52週高點
0.83
52週低點
0.15
成交量
-
平均成交量
-
市值
7.58M
本益比
498.97
股息殖利率
-
股息
-

即將到來

股息

0%股息殖利率
Aug 22
€0.24
Apr 22
€3.59
Oct 21
€2.98
May 19
€0.28
Apr 18
€0.1
10年成長
不適用
5年成長
不適用
3年成長
不適用
1年成長
不適用

財報

3Jun預期
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
下一步
999
333
-333
-999
預期EPS
不適用
實際EPS
不適用

財務

-23.71%利潤率
未盈利
2019
2020
2021
2022
2023
2024
56.69M營收
-13.44M淨利

其他人也在關注

此清單是根據在 Stock Events 上追蹤 NM4.F 的使用者自選建立的。這不是投資建議。

競爭對手

此清單為基於近期市場事件的分析。並非投資建議。

關於

Natus Medical Incorporated provides medical device solutions focuses on the diagnosis and treatment of patients with central nervous and sensory system disorders worldwide. It offers products and technologies used for the screening, detection, treatment, monitoring, and tracking of common medical ailments in newborn care, hearing impairment, neurological and neurosurgical treatments, epilepsy, sleep disorders, and neuromuscular diseases. The company also provides computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology; and software systems for managing and tracking disorders and diseases for public health laboratories. In addition, it offers electroencephalography, long term monitoring, intensive care unit monitoring, electromyography, sleep analysis or polysomnography, and intra-operative monitoring solutions. Further, the company provides hearing assessment, screening, and instrument fitting solutions; jaundice management products; brain injury products; and eye imaging systems and products used in the advanced science and practice of neonatal and pediatric retinal imaging. Additionally, it offers essential products used in the everyday operation of neonatal intensive care unit (NICU); balance assessment systems to evaluate patients with balance disorders; and NICVIEW, a live streaming video for families with babies in the NICU. The company also provides computer-based audiological, otoneurologic, and vestibular instrumentation for hearing and balance care professionals. It serves university medical centers, public and private hospitals, physician offices, clinics, research laboratories, and others. The company was formerly known as ALGOTEK Instruments, Inc. and changed its name to Natus Medical Incorporated in September 1988. Natus Medical Incorporated was incorporated in 1987 and is headquartered in Middleton, Wisconsin. As of July 21, 2022, Natus Medical Incorporated was taken private.
Show more...
執行長
Mr. Thomas Joseph Sullivan
員工
1400
國家
SE
ISIN
SE0007439633
WKN
000A141AR

上市

0 Comments

分享你的想法

FAQ

Vimab Group AB (publ) 今天的股價是多少?
NM4.F 目前價格為 €0.22 EUR,過去 24 小時下跌了 -6.33%。在圖表上更密切關注 Vimab Group AB (publ) 股票的表現。
Vimab Group AB (publ) 的股票代號是什麼?
根據交易所不同,股票代號可能會有所差異。例如,在 交易所,Vimab Group AB (publ) 的股票以代號 NM4.F 進行交易。
Vimab Group AB (publ) 的股價在上漲嗎?
NM4.F 股票較上週下跌 -6.72%,本月上漲 +36.62%,過去一年 Vimab Group AB (publ) 下跌 -70.32%。
Vimab Group AB (publ) 的市值是多少?
今天 Vimab Group AB (publ) 的市值為 7.58M
Vimab Group AB (publ) 下一次財報日期是什麼時候?
Vimab Group AB (publ) 將於 June 03, 2026 公布下一次財報。
Vimab Group AB (publ) 去年的營收是多少?
Vimab Group AB (publ) 去年的營收為 56.69MEUR。
Vimab Group AB (publ) 去年的淨利是多少?
NM4.F 去年的淨收益為 -13.44MEUR。
Vimab Group AB (publ) 會發放股息嗎?
是的,NM4.F 的股息每 年度 發放一次。每股最新股息為 0.24 EUR。截至今日,股息殖利率(FWD)% 為 0%。
Vimab Group AB (publ) 有多少名員工?
截至 April 04, 2026,公司共有 1,400 名員工。
Vimab Group AB (publ) 位於哪個產業?
Vimab Group AB (publ)從事於Energy產業。
Vimab Group AB (publ) 何時完成拆股?
Vimab Group AB (publ) 最近沒有進行任何拆股。
Vimab Group AB (publ) 的總部在哪裡?
Vimab Group AB (publ) 的總部位於 SE 的 Middleton。